Power Medical Interventions, which manufactures computer-assisted instruments for minimally invasive surgeries, priced 3.85 million shares at $11, a -15% discount to the midpoint of its proposed $12-$14 range. Jefferies and Lazard managed the deal for the PA-based company. The stock is expected to begin trading on the NASDAQ on Friday under the ticker PMII.
